Clinical Trial Update: A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Budoprutug for primary membranous nephropathy is currently recruiting, sponsored by Climb Bio, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Budoprutug (Budoprutug)

Snippet

Sponsor: Climb Bio, Inc. | Conditions: Primary Membranous Nephropathy | Phase 2 | Status: RECRUITING